TCT: Toshiba introduces Next Generation CV-3D
Toshiba America Medical Systems has introduced its Next Generation CV-3D, an integrated reconstruction workstation and software package, available on the Infinix-i x-ray product line, at the 2009 Transcatheter Cardiovascular Therapeutics (TCT) meeting this week in San Francisco.
According to Toshiba, Next Generation CV-3D is designed to take a 2D x-ray image and reconstruct a new, more detailed 3D image. The new image provides a 3D reconstructed view of the same vessel under study, allowing physicians to determine the best treatment plan.
The CV-3D visualization system assists physicians in selecting the most appropriate stent, potentially reducing the need for additional invasive devices, according to the Tustin, Calif.-based Toshiba. Some of the latest enhancements optimize stent selection and positioning by automatically including markers in the view and providing a clear view of the stent in relationship to the vessel wall, which validates proper stent deployment, the company said.
According to Toshiba, Next Generation CV-3D is designed to take a 2D x-ray image and reconstruct a new, more detailed 3D image. The new image provides a 3D reconstructed view of the same vessel under study, allowing physicians to determine the best treatment plan.
The CV-3D visualization system assists physicians in selecting the most appropriate stent, potentially reducing the need for additional invasive devices, according to the Tustin, Calif.-based Toshiba. Some of the latest enhancements optimize stent selection and positioning by automatically including markers in the view and providing a clear view of the stent in relationship to the vessel wall, which validates proper stent deployment, the company said.